143 related articles for article (PubMed ID: 8245262)
1. Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study.
Dummer R; Krasovec M; Röger J; Sindermann H; Burg G
J Am Acad Dermatol; 1993 Dec; 29(6):963-70. PubMed ID: 8245262
[TBL] [Abstract][Full Text] [Related]
2. Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas.
Dummer R; Röger J; Vogt T; Becker J; Hefner H; Sindermann H; Burg G
Prog Exp Tumor Res; 1992; 34():160-9. PubMed ID: 1438799
[No Abstract] [Full Text] [Related]
3. Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.
Duvic M; Tetzlaff MT; Gangar P; Clos AL; Sui D; Talpur R
J Clin Oncol; 2015 Nov; 33(32):3759-65. PubMed ID: 26261247
[TBL] [Abstract][Full Text] [Related]
4. Topical imiquimod as treatment for different kinds of cutaneous lymphoma.
Coors EA; Schuler G; Von Den Driesch P
Eur J Dermatol; 2006; 16(4):391-3. PubMed ID: 16935796
[TBL] [Abstract][Full Text] [Related]
5. [Analytical study of 13 cases of cutaneous lymphoma].
Kort R; Mokni M; Rouatbi M; Azaiz MI; Kchir N; Haouet S; Boubaker S; Zitouna M; Ben Osman A
Tunis Med; 1995; 73(6-7):247-52. PubMed ID: 9506173
[No Abstract] [Full Text] [Related]
6. [Cutaneous lymphoma].
Beyeler M; Burg G; Dummer R
Hautarzt; 2004 Oct; 55(10):1005-16; quiz 1017. PubMed ID: 15349694
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance related proteins in primary cutaneous lymphomas.
van Haselen CW; Flens MJ; Scheper RJ; van der Valk P; Scheffer GL; Toonstra J; van Vloten WA
Adv Exp Med Biol; 1999; 457():119-31. PubMed ID: 10500787
[TBL] [Abstract][Full Text] [Related]
9. Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma.
Rook AH; Gelfand JM; Wysocka M; Troxel AB; Benoit B; Surber C; Elenitsas R; Buchanan MA; Leahy DS; Watanabe R; Kirsch IR; Kim EJ; Clark RA
Blood; 2015 Sep; 126(12):1452-61. PubMed ID: 26228486
[TBL] [Abstract][Full Text] [Related]
10. [Cutaneous lymphomas].
Schad K; Baumann Conzett K; Cozzio A
Ther Umsch; 2010 Sep; 67(9):453-64. PubMed ID: 20806174
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor scintigraphy in cutaneous malignant lymphomas.
van den Anker-Lugtenburg PJ; Heule F; Vanhagen PM; van Joost T; Oei HY; Löwenberg B; Krenning EP
J Am Acad Dermatol; 1996 Jun; 34(6):985-93. PubMed ID: 8647992
[TBL] [Abstract][Full Text] [Related]
12. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients.
Unger C; Peukert M; Sindermann H; Hilgard P; Nagel G; Eibl H
Cancer Treat Rev; 1990 Sep; 17(2-3):243-6. PubMed ID: 2272039
[TBL] [Abstract][Full Text] [Related]
13. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients.
Unger C; Sindermann H; Peukert M; Hilgard P; Engel J; Eibl H
Prog Exp Tumor Res; 1992; 34():153-9. PubMed ID: 1438798
[No Abstract] [Full Text] [Related]
14. Therapeutic Efficacy of Etretinate on Cutaneous-type Adult T-cell Leukemia-Lymphoma.
Yonekura K; Takeda K; Kawakami N; Kanzaki T; Kanekura T; Utsunomiya A
Acta Derm Venereol; 2019 Jul; 99(9):774-776. PubMed ID: 31017247
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the management of cutaneous lymphomas.
Belloni B; Johansen N; Glass LF; Dummer R
Semin Oncol; 2012 Apr; 39(2):150-62. PubMed ID: 22484187
[TBL] [Abstract][Full Text] [Related]
16. A phase II trial of miltefosine in patients with cutaneous T-cell lymphoma.
Dumontet C; Thomas L; Bérard F; Gimonet JF; Coiffier B
Bull Cancer; 2006 Nov; 93(11):E115-8. PubMed ID: 17145574
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of denileukin diftitox alternate dosing regimen in patients with cutaneous peripheral T-cell lymphomas.
Talpur R; Duvic M
Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):180-5. PubMed ID: 22521504
[TBL] [Abstract][Full Text] [Related]
18. [Cutaneous B-cell lymphoma treatment with rituximab: two cases].
Viguier M; Bachelez H; Brice P; Rivet J; Dubertret L
Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1152-5. PubMed ID: 12442128
[TBL] [Abstract][Full Text] [Related]
19. Atypical shock and skin lesions revealing lymphoma.
Fenot M; Lassalle V; Maillard H; De Ybarlucea LR; Celerier P
Acta Derm Venereol; 2013 Sep; 93(5):592-3. PubMed ID: 23420349
[No Abstract] [Full Text] [Related]
20. The Potential for Teledermatology in Managing and Diagnosing Patients With Cutaneous Lymphomas.
Beer J; Hadeler E; Nouri K
J Drugs Dermatol; 2020 Nov; 19(11):1125. PubMed ID: 33196742
[No Abstract] [Full Text] [Related]
[Next] [New Search]